Project Details
Description
A Phase I Study of De-immunized DI-Leu16-IL2 Immunocytokine administered subcutaneously in Patients with B-cell Non-Hodgkin Lymphoma (NHL
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/12 → 5/30/18 |
Funding
- ALOPEXX ONCOLOGY LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.